Breast cancer prognosis is poor when total plasminogen activator activity is low
- 1 February 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (2) , 374-378
- https://doi.org/10.1038/bjc.1993.68
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- PROGNOSTIC VALUE OF ESTROGEN AND PROGESTERONE RECEPTORS MEASURED BY ENZYME IMMUNOASSAYS IN HUMAN-BREAST TUMOR CYTOSOLS1989
- ASSOCIATION BETWEEN HIGH-CONCENTRATIONS OF MR 52,000 CATHEPSIN-D AND POOR PROGNOSIS IN PRIMARY HUMAN-BREAST CANCER1989
- UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCERThe Lancet, 1989
- Estrogen Regulation of Human Breast Cancer Cell Line MCF-7 Tissue Plasminogen Activator*Endocrinology, 1989
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988
- EFFECTS OF INHIBITORS OF PLASMINOGEN-ACTIVATOR, SERINE PROTEINASES, AND COLLAGENASE-IV ON THE INVASION OF BASEMENT-MEMBRANES BY METASTATIC CELLS1988
- TISSUE-TYPE PLASMINOGEN-ACTIVATOR, A NEW PROGNOSTIC MARKER IN BREAST-CANCER1988
- INCREASE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-EXPRESSION IN HUMAN-LUNG AND BREAST CARCINOMAS1987
- Do proteases play a role in cancer invasion and metastasis?European Journal of Cancer and Clinical Oncology, 1987
- Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascadeCell, 1986